TABLE 1.
Virus | Viral strain | Viral family | Genome | E/NEa | Cells used in assay | Virus titer controlb | Virus titer Cu filterb | Log10 reduction (mean ± SD)c | P valued |
---|---|---|---|---|---|---|---|---|---|
Rhinovirus 2 | HGP | Picornaviridae | RNA | NE | HeLa Ohio-1 | 4.3/7/7 | 3.3/3/6 | 2 ± 1.7 | 0.2 |
Yellow fever virus | 17D | Flaviviridae | RNA | E | Vero-76 | 6.3/6.3/5.9 | 5.7/4.7/4.8 | 1.1 ± 0.5 | <0.05 |
Influenza A virus | Panama/2007/99 H3N2 | Orthomyxoviridae | RNA | E | MDCK | 7.5/7.5/6.8 | 6.7/5/4.8 | 1.77 ± 0.87 | <0.001 |
Measles virus | Chicago | Paramyxoviridae | RNA | E | CV-1 | 3.67/3.67/3.67 | 0/0/0 | ≥3.67 | <0.001 |
Respiratory syncytial virus | A2 | Paramyxoviridae | RNA | E | MA-104 | 4/4/4 | 3/2/2.5 | 1.5 ± 0.5 | <0.01 |
Parainfluenza virus 3 | 14702 | Paramyxoviridae | RNA | E | MA-104 | 8/8/8 | 7.33/6.33/7 | 1.11 ± 0.5 | <0.05 |
Punta Toro virus | Adames | Bunyaviridae | RNA | E | LLC-MK2 | 7/6.6/6.6 | 3.5/6/5.5 | 1.73 ± 1.55 | 0.09 |
Pichinde virus | AN 4763 | Arenaviridae | RNA | E | BSC-1 | 7.5/7.6/7 | 4.5/5.6/6.9 | 1.7 ± 1.47 | 0.08 |
HIV-1 | IIIB | Retroviridae | RNA | E | MT2 | 6/6.5/6 | 0.8/2.5/1.5 | 4.6 ± 0.6 | 0.001 |
Adenovirus type 1 | Ad-HIVluc | Adenoviridae | DNA | NE | cMAGI | 5/5/5.2 | 2.5/3.2/2.9 | 2.2 ± 0.36 | 0.001 |
Cytomegalovirus | AD169 | Herpesviridae | DNA | E | Fibroblasts | 6/6/6 | 2/1.5/1.6 | 4.3 ± 0.26 | <0.001 |
Vaccinia virus | WR | Poxviridae | DNA | E | Vero-76 | 7.4/7.6/7.6 | 7.4/6.7/7.1 | 0.47 ± 0.45 | 0.095 |
E, enveloped viruses; NE, nonenveloped viruses.
Log10 PFU/ml for vaccinia virus; log10 CCID50/ml for the other viruses.
The log reduction was calculated as log10 CCID50/ml of the titer obtained from the control filter minus log10 CCID50/ml of the filter containing copper oxide. The values are the mean and standard deviation obtained in three separate experiments.
t test between viral titers obtained after filtration in control filters not containing copper versus copper-containing filters.